Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Treatment

Michigan Retailers Free Rx Card Can Help Seniors
A free card from the Michigan Retailers Association can lift some of the weight of concern and worry for seniors buying expensive prescription drugs.
generic viagra online
Admin, Dems Face Challenge In Showing Voters What Reform Means For Them
As health reform proposals emerge from congressional committees, partisan fighting boils and the president wades into the debate with a series of televised addresses, news reports turn to an unanswered question. "What"s in it for me?" asks David Leonhardt, the New York Times business columnist. "On the subject of health care reform, most Americans probably don"t have a good answer to the question. And that, obviously, is a problem for the White House and for Democratic leaders in Congress," he writes.
News of the day
The Challenges Of Avian Influenza Virus: Mechanism, Epidemiology And Control
The latest special issue of Science in China Series C: Life Sciences focuses on the recent progress in the H5N1-related research field.
Public Health

Safe New Treatment Combination For Head And Neck Cancer Patients

Patients undergoing treatment for advanced head and neck cancers may respond well to the addition of gefinitib to chemotherapy, according to a study sponsored by the Eastern Cooperative Oncology Group and chaired by Ethan Argiris, M.D., associate professor of medicine, University of Pittsburgh School of Medicine, and co-leader of the Head and Neck Cancer Program of the University of Pittsburgh Cancer Institute (UPCI). The results were disclosed at the 45th annual meeting of the American Society of Clinical Oncology (ASCO) on May 30 in Orlando, Fla. "We found that adding gefinitib to standard chemotherapy was well-tolerated by patients who had already received chemotherapy or were frail," said Dr. Argiris. "We had hoped this study would improve the survival rate of patients, but while gefinitib did postpone spread of the disease, it did not increase survival rates. The finding that the addition of gefinitib to chemotherapy can delay the growth of head and neck cancer suggests a potential beneficial effect from combination therapy." One group of 136 patients in the placebo-controlled study received docetaxel alone, a standard treatment for head and neck cancer. A second group of 134 patients received gefinitib in addition to docetaxel. This was the first phase III randomized trial to examine the addition of gefinitib to chemotherapy for patients with head and neck cancer. Gefinitib, which also is known by the trade name Iressa, is a targeted therapy against the epidermal growth factor receptor (EGFR) with fewer side effects than traditional chemotherapies. Patients were able to take the drug orally and tolerated it well. Dr. Argiris plans to conduct further studies to identify the subsets of patients most likely to respond to the drug and to examine patients" quality of life while taking the combination therapy. Head and neck cancers are a group of biologically similar cancers originating from the upper aerodigestive tract, including the lip, mouth, nasal cavity, paranasal sinuses, pharynx and larynx that affect more than 45,000 individuals in the U.S. each year. Head and neck cancers are strongly associated with environmental and lifestyle risk factors, including tobacco smoking, alcohol consumption and certain strains of the sexually transmitted human papilloma virus. Courtney McCrimmon University of Pittsburgh Schools of the Health Sciences


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009